跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 峻宇
副教授
數據科學與工程研究所
https://orcid.org/0000-0003-2901-2681
h-index
h10-index
h5-index
451
引文
13
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
390
引文
13
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
96
引文
5
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2009
2024
每年研究成果
概覽
指紋
網路
計畫
(4)
研究成果
(32)
獎項
(7)
類似的個人檔案
(6)
指紋
查看啟用 Chun-Yu Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Protein-protein Interaction
76%
Head-and-neck Cancer
59%
Heterologous Protein
57%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
56%
Web Server
55%
Chronic Myeloid Leukemia
51%
Cell Apoptosis
46%
Histone Deacetylase Inhibitor (HDACi)
44%
Protein-protein Interaction Network
43%
Apoptosis Assay
42%
Detection Sensor
42%
Advanced Thyroid Cancer
41%
Gene Signature
40%
Evolutionary Profile
38%
Cancer Subtypes
36%
Histone Deacetylase 1 (HDAC1)
36%
Human Cancer
36%
Prostate Cancer
36%
Genetic Profile
36%
Deep Learning
36%
Imatinib Resistance
36%
Cell Growth
36%
Anaplastic Thyroid Cancer
33%
Feature Based Strategy
32%
Thyroid Cancer
31%
Evolutionary Conservation
30%
SW579
30%
Cas9 Protein
30%
Targeted Therapy
29%
Genome Editing
28%
Gene Expression Data
27%
Triple-negative Breast Cancer
27%
K562 Cells
27%
Panobinostat
26%
Imatinib
25%
Histone Deacetylase 2 (HDAC2)
25%
Cancer Genes
25%
Biological Function
24%
Cancer Cell Death
24%
Metastasis
23%
Bioinformatics
22%
Image-based
22%
Core Gene Set
22%
Epidermal Growth Factor Receptor
22%
Leukemia Patients
22%
Differentially Expressed Genes
22%
Knock
22%
Prognostic Biomarker
20%
Thyroid Cancer Cell Lines
20%
Gene Set
20%
Biochemistry, Genetics and Molecular Biology
Genomics
100%
Gene Expression
82%
Protein-Protein Interaction
80%
Imatinib
48%
Protein-Protein Interaction Networks
45%
Cancer Cell
45%
Myeloid
44%
Programmed Cell Death
43%
Genetic Conservation
39%
RNA Sequencing
37%
DNA Template
36%
Gene Signature
36%
Carcinogenesis
36%
Evolution
36%
Real-Time Polymerase Chain Reaction
32%
Biological Functions
30%
Oncogene
27%
Animal Model
27%
Tumor-Related Gene
27%
CRISPR/Cas9
27%
K562 Cells
25%
Essential Gene
22%
Protein Expression
20%
Mouse Model
20%
Smoking
20%
Cell Growth
19%
Biological Phenomena and Functions Concerning the Entire Organism
19%
Protein Complexes
18%
Differential Gene Expression
18%
Cellular, Subcellular and Molecular Biological Phenomena and Functions
18%
Steady State
18%
Ferroptosis
18%
ABL (Gene)
18%
Genetics
18%
Platelet-Derived Growth Factor Receptor
18%
Antigen Specificity
18%
Immune Response
18%
Lentivirus
18%
Nicotinic Acetylcholine Receptor
18%
Single-Cell Analysis
18%
Platelet Derived Growth Factor Receptor Alpha
18%
CHRNB4
18%
Albendazole
18%
Immune Checkpoints
18%
Cancer Mortality
18%
Binding Protein
18%
Protein Function
18%
Transmembrane Protein
18%
Membrane Protein
18%
Information Systems
18%
Medicine and Dentistry
Programmed Cell Death
62%
Thyroid Cancer
45%
Cancer
43%
In Vitro
39%
HDAC1
36%
Clustered Regularly Interspaced Short Palindromic Repeat
34%
Cas9
34%
Malignant Neoplasm
32%
Imatinib
30%
Metastatic Carcinoma
30%
Cell Death
30%
Anaplastic Thyroid Carcinoma
29%
Cancer Cell
28%
Triple Negative Breast Cancer
27%
Chronic Myelogenous Leukemia
26%
Histone Deacetylase Inhibitor
25%
Breast Cancer
25%
Lung Metastasis
25%
K562 Cells
22%
Histone Deacetylase 2
22%
Knock Out
22%
Carcinogenicity
20%
Panobinostat
20%
Neoplasm
18%
Receptor Subunit
18%
Leukemia Cell
18%
Genome Editing
18%
Anaplastic Carcinoma
18%
Histone
18%
Platelet Derived Growth Factor Receptor
18%
Receptor Subtype
18%
Nicotinic Receptor
18%
Deacetylation
18%
Head and Neck Cancer
18%
Ferroptosis
18%
Circulating Tumor Cell
18%
Immune Checkpoint Inhibitor
18%
Epidermal Growth Factor Receptor
18%
Carcinogenesis
18%
Membrane Protein
18%
Immunity
18%
Cell Cycle Arrest
16%
Cell Cycle Checkpoint
16%
Cell Growth
14%
Head and Neck Squamous Cell Carcinoma
13%
Biological Marker
12%
Thyroid Gland
12%
Virus
11%
Lentivirus
11%
Gene Expression
11%